Press ESC to close

    Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

    Stifel initiated coverage on Compass Pathways plc, saying, “The Time Is Now for Psychedelics.

    Compass is a clinical-stage biotechnology company focused on developing psychedelics-based drugs for neuropsychiatric disorders.

    The analyst equates COMP360 to Spravato 2.0. Johnson & Johnson’s Spravato (esketamine) is a nasal spray for TRD and major depressive disorder (MDD), selling over ~$1 billion annually.

     

    Read more on Benzinga
    Buzz

    Buzz

    At 420 Intel, we cover cannabis legalization news throughout the world, offer reliable information for cannabis business owners, detail technological advances that impact the marijuana industry, cover marijuana rallies from across the globe, and everything in between.

    Marijuana Business News
    Inside The First Black And Latina-Owned Vertically Integrated Cannabis Company In The US
    • Buzz
      Buzz
    • 12 February 2025

    Inside The First Black And Latina-Owned Vertically Integrated Cannabis Company In The US

    In a rapidly evolving cannabis industry, where social equity remains an ongoing challenge, Standard...

    Cannabis Technology News
    Canapa Expands Portfolio with Comac Beverage Processing and Filling Solutions
    • Buzz
      Buzz
    • 10 October 2024

    Canapa Expands Portfolio with Comac Beverage Processing and Filling Solutions

    Canapa by Paxiom is excited to announce the addition of Comac Beverage processing and filling...

    Marijuana Business News
    Billions Wiped of US Cannabis Companies’ Market Value Amid Mixed Financial Performance in Q3
    • Buzz
      Buzz
    • 12 November 2024

    Billions Wiped of US Cannabis Companies’ Market Value Amid Mixed Financial Performance in Q3

    US cannabis companies have endured a significant selloff in the days following the results of the...